Leipzig Interventional Course (LINC), a high-end international academic conference in peripheral vascular field, was opened in Leipzig, Germany, on January 24, 2017. LifeTech Scientific Corporation, as one of the few Chinese enterprises to be invited to the academic event, showcased its innovative endovascular products. 

 

In the morning of January 26, 2017, Prof. LUO Jianfang, Director of Vascular Treatment Center, Guangdong General Hospital, made a presentation entitled "Uptake of 18F-FDG: New Predictor for Type B IMH Progression". In the presentation, he mentioned and demonstrated the Ankura™ Thoracic Stent Graft System, which independently researched and developed by LifeTech Scientific Corporation, recommending it based on his deep expertise and years of experience in the industry. 

 

(Image: Prof. LUO Jianfang demonstrates LifeTech's Ankura™ Thoracic Stent Graft System)

The presentation session was followed by a TEVAR live case, performed by Dr. A. Schmidt and Dr. D. Branzan from University Hospital Leipzig using LifeTech's Ankura™ Thoracic Stent Graft System, and with Prof. Theodoros Kratimenos from EVAGGELISMOS General Hospital of Athens, Greece, a leading expert in cardiovascular field, providing guidance and advice for the operation. The patient receiving the operation was diagnosed with acute Type B aortic dissection six weeks ago. As the lesion involved the descending aorta of the patient, it required the implantation of two Lifetech`s Ankura™ Thoracic Stent Grafts in the operation.   

(Image: Dr. A. Schmidt and Dr. D. Branzan perform the operation using LifeTech's Ankura™ Thoracic Stent Graft System)

The operation was highly successful, taking less than half an hour, with the first stent being implanted in approximately ten minutes after the operation began. Postoperative angiography indicated that the stents were well deployed with patency blood flow and no endoleak. 

 

(Image: The Ankura™ Thoracic Stent Grafts are well deployed with no endoleak)

 

"It looks beautiful to me. Good job!” said the conference chair after viewing the postoperative angiographs. Prof. Theodoros Kratimenos also spoke highly of the live case, adding that it marked a milestone for LifeTech in the international cardiovascular intervention market. 

 

Since its launch in 2004, Ankura™ Thoracic Stent Graft System has been widely recognized by specialists for its excellent design and outstanding performance. It boasts extensive strengths, including unique multi-taper design for excellent conformity to the natural curvature of the aorta, tip capture mechanism for controlled deployment and precise placement, no-suture of the main body and e-PTFE dual membrane making it no-endoleak, and outstanding compliance and apposition, giving it a clear edge over competitors. 

 

  (Image: Ankura™ Thoracic Stent Graft System)

 

In addition to that, LifeTech's booth attracted many prospective partners from Europe, Middle East and Latin America for exchanges on products and discussions on potential cooperation opportunities. 

 

(Image: LifeTech's Booth)

 

LINC 2017 drew to a close on January 27. LifeTech's standout performance at this top-notch international academic event not only laid a foundation for its development in the European market but also opened up the door for it to expand its presence in global markets and therefore holds far-reaching implications for the company's business development globally. Going forward, LifeTech will continue pushing ahead with independent innovation and developing more cardiovascular interventional medical devices for safer and more convenient to treat cardiovascular diseases, bringing the benefits of technology to every corner of the world!